CVS Health Corporation $CVS Stock Acquired by Voya Investment Management LLC

Voya Investment Management LLC raised its position in CVS Health Corporation (NYSE:CVS – Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 463,422 shares of the pharmacy operator’s stock after acquiring an additional 27,717 shares during the quarter. Voya Investment Management LLC’s holdings in CVS Health were worth $39,711,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in CVS. Elevation Wealth Partners LLC grew its stake in CVS Health by 41.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 356 shares of the pharmacy operator’s stock worth $37,000 after purchasing an additional 105 shares in the last quarter. HBW Advisory Services LLC lifted its stake in CVS Health by 3.5% in the third quarter. HBW Advisory Services LLC now owns 3,408 shares of the pharmacy operator’s stock worth $292,000 after acquiring an additional 115 shares during the last quarter. Apella Capital LLC grew its holdings in CVS Health by 1.7% during the 2nd quarter. Apella Capital LLC now owns 6,940 shares of the pharmacy operator’s stock worth $724,000 after acquiring an additional 117 shares in the last quarter. Wellington Altus USA Inc. lifted its position in shares of CVS Health by 13.3% during the 2nd quarter. Wellington Altus USA Inc. now owns 1,025 shares of the pharmacy operator’s stock worth $106,000 after purchasing an additional 120 shares during the last quarter. Finally, Childress Capital Advisors LLC increased its holdings in CVS Health by 3.9% in the third quarter. Childress Capital Advisors LLC now owns 3,497 shares of the pharmacy operator’s stock valued at $300,000 after buying an additional 131 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the subject of several recent analyst reports. Wells Fargo & Company reduced their price objective on shares of CVS Health from $123.00 to $112.00 and set an “overweight” rating for the company in a research report on Thursday, November 12th. Sanford C. Bernstein reiterated an “outperform” rating on shares of CVS Health in a research report on Friday, November 13th. Piper Sandler set a $106.00 price target on CVS Health in a research note on Friday, November 13th. Weiss Ratings raised shares of CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, November 9th. Finally, Leerink Partners dropped their price target on CVS Health from $112.00 to $104.00 and set an “outperform” rating on the stock in a research report on Thursday, November 5th. Twenty-three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $107.33.

View Our Latest Research Report on CVS Health

CVS Health News Summary

Here’s some of the latest news about CVS:

  • Positive Sentiment: CVS ranked ninth on a list of 10 affordable blue-chip stocks, which may support its appeal to value-oriented investors. The ranking is editorial and does not reflect a company earnings update. Why CVS Health Cracked the Best Affordable Blue Chip Stocks List
  • Neutral Sentiment: CVS plans a multiyear separation into healthcare-services and retail-pharmacy companies. The move could sharpen each business’s focus, but the transition also brings execution uncertainty. CVS Health plans a company breakup
  • Negative Sentiment: Reports of growing Medicare-for-All momentum weighed on health-insurer shares, raising concerns about potential pressure on insurers’ business models, pricing and reimbursement. Medicare For All Momentum Sinks Health Insurer Stocks

Insider Activity at CVS Health

In other CVS Health news, EVP Prem Shah acquired 23,855 shares of the stock in a transaction that occurred on Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the purchase, the executive vice president owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.85% of the stock is owned by corporate insiders.

CVS Health Price Performance

CVS Health stock opened at $80.09 on Friday. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.66 and a current ratio of 0.85. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The company has a market cap of $102.47 billion, a P/E ratio of 9.32, a price-to-earnings-growth ratio of 0.71 and a beta of 0.58. The business has a fifty day moving average of $88.69 and a two-hundred day moving average of $89.27.

CVS Health (NYSE:CVS – Get Free Report) last issued its earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, topping the consensus estimate of $1.65 by $0.44. The company had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.60 earnings per share. As a group, analysts predict that CVS Health Corporation will post 8.26 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd were issued a $0.6650 dividend. The ex-dividend date of this dividend was Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio is 30.97%.

CVS Health Company Profile

(Free Report)

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Further Reading

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.